Schrödinger Company
Schrödinger’s industry-leading computational platform facilitates the research efforts of biopharmaceutical and industrial companies, academic institutions and government laboratories worldwide. Schrödinger also has wholly-owned and collaborative drug discovery programs in a broad range of therapeutic areas. Schrödinger is deeply committed to investing in the science and talent that drive its computational platform. Schrödinger was founded in 1990, has over 400 employees and is engaged with customers and collaborators in more than 70 countries. To learn more visit www.schrodinger.com.
Investors
%20.jpg)
Funding Status:
IPO
Headquarters:
New York, New York, United States
Zip:
NA
Acquisitions Number:
NA
Founded Date:
1990-08-16
Employee Number:
251-500
Last Funding Type:
Grant
Total Funding:
567224987.0
Estimated Revenue:
$50M to $100M
Industry:
Early Drug Development
Investors Number:
16.0
Investor Type:
IPO
Last Funding Date:
2021-11-18
Number Of Exists:
1